Position in GLUE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$90,300,267
+$35,127,296 QoQ
Shares Held
3,731,416
+11.3% QoQ
Ownership
4.37%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 193 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,552,510,511 across 411 Biotechnology names. GLUE ranks #85 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in GLUE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $90,300,267 | 3,731,416 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $55,172,971 | 3,353,980 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $33,045,286 | 2,107,480 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $6,274,587 | 846,773 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,751,503 | 831,819 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,717,832 | 801,257 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,470,424 | 1,076,430 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,644,158 | 687,577 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,378,954 | 636,084 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,337,519 | 615,251 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,239,760 | 573,409 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,839,310 | 592,758 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,075,989 | 595,035 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,134,511 | 530,746 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,937,231 | 517,376 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $3,958,945 | 484,571 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $4,359,854 | 450,864 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,181,343 | 369,568 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,075,341 | 199,576 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,376,355 | 151,542 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||